INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 125 filers reported holding INTERSECT ENT INC in Q3 2021. The put-call ratio across all filers is 3.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,674,000 | -1.0% | 345,352 | -3.5% | 0.00% | 0.0% |
| Q4 2021 | $9,769,000 | -2.3% | 357,705 | -2.7% | 0.00% | 0.0% |
| Q3 2021 | $10,002,000 | +55.7% | 367,707 | -2.2% | 0.00% | +100.0% |
| Q2 2021 | $6,424,000 | -19.9% | 375,853 | -2.2% | 0.00% | 0.0% |
| Q1 2021 | $8,020,000 | -16.4% | 384,127 | -8.3% | 0.00% | -50.0% |
| Q4 2020 | $9,589,000 | +35.0% | 418,768 | -3.9% | 0.00% | 0.0% |
| Q3 2020 | $7,105,000 | +14.6% | 435,657 | -4.9% | 0.00% | +100.0% |
| Q2 2020 | $6,200,000 | +21.5% | 457,940 | +6.3% | 0.00% | 0.0% |
| Q1 2020 | $5,104,000 | -51.0% | 430,745 | +2.9% | 0.00% | -50.0% |
| Q4 2019 | $10,419,000 | +41.9% | 418,452 | -3.1% | 0.00% | 0.0% |
| Q3 2019 | $7,344,000 | -21.0% | 431,763 | +5.8% | 0.00% | 0.0% |
| Q2 2019 | $9,292,000 | -29.1% | 408,276 | +0.1% | 0.00% | -33.3% |
| Q1 2019 | $13,107,000 | +15.5% | 407,704 | +1.2% | 0.00% | 0.0% |
| Q4 2018 | $11,348,000 | -3.6% | 402,682 | -1.7% | 0.00% | 0.0% |
| Q3 2018 | $11,777,000 | -19.9% | 409,640 | +4.3% | 0.00% | -25.0% |
| Q2 2018 | $14,710,000 | +5.4% | 392,794 | +10.7% | 0.00% | 0.0% |
| Q1 2018 | $13,952,000 | +22.0% | 354,976 | +0.6% | 0.00% | +33.3% |
| Q4 2017 | $11,435,000 | +3.0% | 352,940 | -1.0% | 0.00% | 0.0% |
| Q3 2017 | $11,106,000 | +11.7% | 356,520 | +0.2% | 0.00% | 0.0% |
| Q2 2017 | $9,947,000 | +72.6% | 355,864 | +5.9% | 0.00% | +50.0% |
| Q1 2017 | $5,762,000 | +38.4% | 336,025 | -2.3% | 0.00% | +100.0% |
| Q4 2016 | $4,163,000 | -26.9% | 343,993 | -4.3% | 0.00% | -50.0% |
| Q3 2016 | $5,692,000 | +26.3% | 359,282 | +3.1% | 0.00% | +100.0% |
| Q2 2016 | $4,506,000 | -34.8% | 348,431 | +2.6% | 0.00% | -50.0% |
| Q1 2016 | $6,915,000 | -7.3% | 339,726 | +2.5% | 0.00% | 0.0% |
| Q4 2015 | $7,457,000 | +38.1% | 331,435 | +43.7% | 0.00% | 0.0% |
| Q3 2015 | $5,398,000 | +112.4% | 230,684 | +159.9% | 0.00% | +100.0% |
| Q2 2015 | $2,541,000 | +24.4% | 88,752 | +12.2% | 0.00% | 0.0% |
| Q1 2015 | $2,043,000 | +39.4% | 79,090 | +0.1% | 0.00% | – |
| Q4 2014 | $1,466,000 | +182.5% | 79,005 | +136.1% | 0.00% | – |
| Q3 2014 | $519,000 | – | 33,468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |